Serum 1,5-anhydroglucitol: Risk factor of acute ischemic stroke and transient ischemic attack in well-controlled diabetes
Cerebrovascular Diseases Nov 01, 2017
Shiga Y, et al. - In this study, experts sought to assess whether serum 1,5-anhydroglucitol (1,5-AG) could be a possible marker of acute ischemic stroke (AIS) or transient ischemic attacks (TIA) in patients with diabetes mellitus (DM). Among patients with well-controlled DM, low serum 1,5-AG levels could be a possible marker for AIS/TIA risk.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty -
Paid Market Research Surveys -
Case discussions, News & Journals' summaries
